Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/37064880http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37064880http://www.w3.org/2000/01/rdf-schema#comment"Aims: The invasive intramyocardial injection of mesenchymal stromal cells (MSCs) allows for limited repeat injections and shows poor therapeutic efficacy against ischemic heart failure. Intravenous injection is an alternative method because this route allows for repeated, noninvasive, and easy delivery. However, the lack of targeting of MSCs hinders the ability of these cells to accumulate in the ischemic area after intravenous injections. We investigated whether and how the overexpression of colony-stimulating factor 2 receptor beta subunit (CSF2RB) may regulate the cardiac homing of MSCs and their cardioprotective effects against ischemic heart failure. Methods and Results: Adult mice were subjected to myocardial ischemia/reperfusion (MI/R) or sham operations. We observed significantly higher CSF2 protein expression and secretion by the ischemic heart from 1 day to 2 weeks after MI/R. Mouse adipose tissue-derived MSCs (ADSCs) were infected with adenovirus harboring CSF2RB or control adenovirus. Enhanced green fluorescent protein (EGFP)-labeled ADSCs were intravenously injected into MI/R mice every three days for a total of 7 times. Compared with ADSCs infected with control adenovirus, intravenously delivered ADSCs overexpressing CSF2RB exhibited markedly increased cardiac homing. Histological analysis revealed that CSF2RB overexpression significantly enhanced the ADSC-mediated proangiogenic, antiapoptotic, and antifibrotic effects. More importantly, ADSCs overexpressing CSF2RB significantly increased the left ventricular ejection fraction and cardiac contractility/relaxation in MI/R mice. In vitro experiments demonstrated that CSF2RB overexpression increases the migratory capacity and reduces the hypoxia/reoxygenation-induced apoptosis of ADSCs. We identified STAT5 phosphorylation as the key mechanism underlying the effects of CSF2RB on promoting ADSC migration and inhibiting ADSC apoptosis. RNA sequencing followed by cause-effect analysis revealed that CSF2RB overexpression increases the expression of the ubiquitin ligase RNF4. Coimmunoprecipitation and coimmunostaining experiments showed that RNF4 binds to phosphorylated STAT5. RNF4 knockdown reduced STAT5 phosphorylation as well as the antiapoptotic and promigratory actions of ADSCs overexpressing CSF2RB. Conclusions: We demonstrate for the first time that CSF2RB overexpression optimizes the efficacy of intravenously delivered MSCs in the treatment of ischemic heart injury by increasing the response of the MSCs to a CSF2 gradient and CSF2RB-dependent STAT5/RNF4 activation."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.org/dc/terms/identifier"doi:10.7150/thno.81336"xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Gao C."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Fan M."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Fan Y."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Guo Y."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"He Y."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Li C."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Gao F."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Li W."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Ding F."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Peng L."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Tao L."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Zhang X."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Zhao H."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Qi T."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Xia Y."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Yan W."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Xu X."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Yu M."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Gao E."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/author"Hai C."xsd:string
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37064880http://purl.uniprot.org/core/name"Theranostics"xsd:string
▶